There is a desperate need for novel therapies to improve the clinical outcome of TNBC. Imugene expects CHECKvacc to provide an improved outcome for women diagnosed with TNBC each year. Last year, the City of Hope® dosed the second patient in the Phase I clinical trial of CHECKvacc. Watch this video on Kalkine TV.
Imugene Limited tapping breast cancer market via oncolytic virus CHECKvacc
GET A FREE STOCK REPORT
Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.
Recent Articles
Cryptocurrency
Did Legend X hackathon trigger Aelf (ELF) crypto rally on Friday?
- May 27, 2022 08:25 AM PDT
- Versha Jain
Cryptocurrency
Why XCAD Network (XCAD) token's trading volume surged over 100%?
- May 27, 2022 07:44 AM PDT
- Versha Jain
Economy
Focus on renewables, EVs: Inside Albanese govt climate plans
- May 28, 2022 12:36 AM AEST
- Nitish Kumar
![COMMODITY SUPER RUN | Rapid Fire with 4 ASX Players [Lithium, Gold, Copper]](https://kalkinemedia.com/storage/uploads/small/1653650398_6290b3de01910_microsoftteams-image.png "COMMODITY SUPER RUN | Rapid Fire with 4 ASX Players [Lithium, Gold, Copper]")
.png "Why is Ethereum Classic (ETC) crypto gaining attention?,")
.png "How can AI, machine learning transform healthcare sector?")
.png "Language AI startups are here to stay | Expert talks with Felix Laumann")
.png "The Impact of Australia’s new Federal government will have on the Uluru Statement.")
.png "Which ASX Penny Stocks delivered major gains on May 27?")
Be the First to Comment